Novartis AG reported profit below analysts’ estimates and an unexpected sales decline as some of its best-selling medicines were hard hit by generic competition.
www.bloomberg.com
#Novartis #Profit #Sales #Decline #Generic #Competition #Bites
Novartis Profit, Sales Decline as Generic Competition Bites
